Georgetown Lombardi Comprehensive Cancer Center
Go to About
Go to Patients & Families
Go to Living with Cancer
Go to Education & Events
Go to Healthcare Professionals
Go to Newsroom
Every survivor of a gastrointestinal cancer has unique follow-up needs. A road map for this process can help.
On National Doctors’ Day, the Colorectal Cancer Alliance interviewed Dr. John Marshall.
John Marshall, MD, explains that health care providers need to retool their thinking when young people present with GI complaints, and be open to the possibility that these could indicate colon cancer.
For two years, 34-year-old Diana Zepeda thought her GI symptoms were caused by stress and diet.
Nurses can help coach and push patients and their physicians along to do the steps that are needed to get good screening, says John Marshall, MD.
The Food and Drug Administration (FDA) granted priority review to the combination use of Opdivo (nivolumab) and Yervoy (ipilimumab) to treat a subgroup of patients with metastatic colorectal cancer.
John Marshall, MD, recently discussed the treatment options and decisions he makes when treating patients with metastatic colorectal cancer.
“You always read in magazines, ‘I never thought it’d happen to me.’ And now I’m that person in the magazine."
John L. Marshall, MD, and Fadi Braiteh, MD, and share their perspectives on the approval of liposomal irinotecan and review data from the NAPOLI-1 trial in pancreatic cancer.
John L. Marshall, MD, and Fadi Braiteh, MD, discuss the importance of considering sequencing strategies prior to choosing a frontline regimen in pancreatic cancer.